NABL Certified Labs

Book PR3-ANCA (C-ANCA) Test in Pondicherry

35+ Regional Processing Labs
4500+ Serviceable Pincodes across India
75000+ Samples Processed Daily

Test Price

₹1,342

Book Now
Free Home Collection Reports in 24 Hrs

Quick Pr3 Anca C Anca Test Overview in Pondicherry

Also Known As C-ANCA Test, Anti-Proteinase 3 Antibody, Wegener's Antibody
Sample Type Blood (Serum)
Fasting Required No
Report Delivery Within 24 hours
Age Group Adults
Gender All
Test Type Enzyme-Linked Immunosorbent Assay (ELISA)
Units U/mL or Titre
1

The PR3-ANCA test is a blood test that detects antibodies directed against proteinase 3, a serine protease stored in the azurophilic granules of neutrophils and monocytes, which produce the cytoplasmic staining pattern on indirect immunofluorescence testing known as c-ANCA. These antibodies belong to the broader family of antineutrophil cytoplasmic antibodies and are among the most diagnostically specific autoantibodies known in clinical immunology, serving as the primary serological marker for granulomatosis with polyangiitis, formerly known as Wegener's granulomatosis, one of the most serious systemic vasculitides affecting small and medium-sized blood vessels throughout the body. ANCA-associated vasculitides are a group of autoimmune conditions in which autoantibodies directed against neutrophil granule proteins cause neutrophil activation, endothelial damage, and transmural inflammation of blood vessel walls, producing necrotising granulomatous inflammation predominantly affecting the upper respiratory tract, lungs, and kidneys. In granulomatosis with polyangiitis, the classical triad involves necrotising granulomatous inflammation of the upper airways including sinuses, nose, and trachea, lower respiratory tract involvement with pulmonary nodules and haemorrhage, and rapidly progressive glomerulonephritis that can lead to permanent renal failure if not treated promptly with immunosuppressive therapy. In India, ANCA-associated vasculitis was historically considered rare but is increasingly recognised as diagnostic awareness improves and immunological testing becomes more accessible. Delayed diagnosis remains a significant clinical challenge as the multisystem presentation of granulomatosis with polyangiitis mimics many common conditions, and patients frequently undergo prolonged diagnostic workups before the correct diagnosis is established. The test is performed on a small blood sample drawn from a vein and completed in under five minutes.
2

Doctors prescribe a PR3-ANCA test in the following situations: Diagnosing granulomatosis with polyangiitis in patients presenting with the classical triad of chronic sinusitis, saddle nose deformity or septal perforation, pulmonary infiltrates or haemoptysis, and haematuria with red cell casts on urinalysis where positive PR3-ANCA alongside compatible histology confirms the diagnosis and enables immediate immunosuppressive treatment initiation to prevent irreversible organ damage. Investigating rapidly progressive glomerulonephritis in patients with acute kidney injury, haematuria, proteinuria, and red cell casts on urine microscopy where PR3-ANCA positivity identifies ANCA-associated glomerulonephritis as the cause and mandates urgent renal biopsy confirmation followed by high-dose corticosteroid and cyclophosphamide or rituximab therapy to preserve renal function. Evaluating pulmonary renal syndrome in patients with concurrent alveolar haemorrhage and acute glomerulonephritis where the combination of haemoptysis, diffuse alveolar infiltrates, and renal impairment represents a life-threatening emergency requiring immediate ANCA testing alongside anti-GBM antibodies to distinguish granulomatosis with polyangiitis from Goodpasture syndrome and guide emergency treatment. Assessing unexplained chronic sinusitis, otitis media, subglottic stenosis, and destructive upper airway disease in patients who have failed standard ENT treatments where PR3-ANCA testing identifies the autoimmune vasculitic aetiology that requires systemic immunosuppression rather than local or antibiotic treatment. Monitoring disease activity and treatment response in confirmed granulomatosis with polyangiitis patients where serial PR3-ANCA titres during remission maintenance provide early warning of impending disease relapse, though titre trends must be interpreted alongside clinical symptoms and inflammatory markers rather than used in isolation for treatment decisions. Distinguishing granulomatosis with polyangiitis from other ANCA-associated vasculitides including microscopic polyangiitis and eosinophilic granulomatosis with polyangiitis where the PR3-ANCA versus MPO-ANCA distinction has important implications for relapse risk, treatment duration, and long-term disease management strategy.
3

The PR3-ANCA test measures the concentration of IgG antibodies directed against proteinase 3 in the blood serum, expressed in Units per millilitre (U/mL) or as a titre. Results are reported as negative, weakly positive, or positive with quantitative values depending on the laboratory platform used. The generally accepted negative threshold is below 2 U/mL, though cut-off values may vary between laboratory platforms and should be interpreted using the specific laboratory's reference range. Negative (Below 2 U/mL) A negative PR3-ANCA result makes granulomatosis with polyangiitis significantly less likely in a patient being investigated for suspected ANCA-associated vasculitis, though it does not entirely exclude the diagnosis as approximately 10 to 20 percent of confirmed granulomatosis with polyangiitis cases may be ANCA-negative, particularly those with limited disease confined to the upper respiratory tract. Clinical correlation with symptoms, imaging, and tissue biopsy remains essential when clinical suspicion is high despite a negative serology. Weakly Positive (2 to 10 U/mL) A weakly positive result requires careful clinical correlation as low-level PR3-ANCA positivity can occasionally be seen in other inflammatory conditions including other autoimmune diseases, chronic infections, and inflammatory bowel disease. In a patient with compatible clinical features, even a weakly positive result warrants further investigation including MPO-ANCA testing, urine microscopy, chest imaging, and consideration of tissue biopsy for definitive histological confirmation. Positive (Above 10 U/mL) A positive PR3-ANCA result in a patient with compatible clinical features including upper airway disease, pulmonary involvement, and renal impairment is highly specific for granulomatosis with polyangiitis and in the appropriate clinical context is sufficient to initiate urgent treatment while awaiting histological confirmation. High titres are associated with more severe and active disease and predict a higher risk of relapse during remission, warranting closer monitoring and potentially longer duration of maintenance immunosuppressive therapy.
4

No fasting is required for the PR3-ANCA test, as food and fluid intake do not affect autoantibody concentrations in the blood. The test can be performed at any time of day and is typically ordered as part of an urgent vasculitis or glomerulonephritis workup without any specific dietary preparation needed, and in acute presentations is performed immediately regardless of fasting status given the clinical urgency. Inform your doctor about all immunosuppressive medications currently being taken, particularly corticosteroids, rituximab, cyclophosphamide, azathioprine, and mycophenolate mofetil, as these agents suppress autoantibody production and may produce a falsely negative or low-titre result in a patient with active ANCA-associated vasculitis who has already commenced treatment, potentially underestimating disease activity or delaying escalation of therapy. The PR3-ANCA test is ideally ordered simultaneously with MPO-ANCA, complement levels C3 and C4, anti-GBM antibody, ANA, renal function tests, and urine microscopy as part of a comprehensive vasculitis and glomerulonephritis serological panel, as the combination of these tests provides the most complete and diagnostically efficient characterisation of the underlying autoimmune process. Inform your doctor about recent infections, as acute infections can transiently elevate ANCA levels and produce false positive results requiring repeat testing after resolution of the acute infective episode. Staying well hydrated before the blood draw facilitates easier venous access and a smooth collection experience.
5

If you are booking through the SecondMedic platform the PR3-ANCA test price in Pondicherry can cost you around Rs. 1342. You may also consider booking a comprehensive ANCA vasculitis panel that includes PR3-ANCA alongside MPO-ANCA, anti-GBM antibody, ANA, complement levels, renal function tests, and urine microscopy for a complete serological evaluation of suspected vasculitis and glomerulonephritis at a bundled price on SecondMedic.
6

SecondMedic offers convenient home sample collection for the PR3-ANCA test in Pondicherry, making it easy to get tested without visiting a diagnostic centre. Home collection is available free of charge for orders above Rs. 300. A trained phlebotomist will visit your preferred address between 7 AM and 10 PM, seven days a week, including Sundays and public holidays. Your blood sample is processed at NABL-accredited partner laboratories, and your report is delivered within 24 hours directly to your WhatsApp and email.

Our Presence In India

People Also Ask

Yes, the PR3-ANCA test is fully available in Pondicherry through SecondMedic. You can book online and a trained phlebotomist will collect your sample at home at your preferred time.

The PR3-ANCA test price in Pondicherry on the SecondMedic platform is approximately Rs. 1342. Prices may vary slightly based on the package selected at the time of booking.

Your PR3-ANCA test report will be delivered within 24 hours of sample collection. Reports are shared directly to your WhatsApp and email for easy and immediate access.

Samples collected in Pondicherry are processed at NABL-accredited partner laboratories. This ensures accuracy, reliability, and strict adherence to national diagnostic quality standards.

Yes, home sample collection for the PR3-ANCA test is available in Pondicherry. A certified phlebotomist will visit your address at a time slot that is most convenient for you.

Yes, home collection is available seven days a week in Pondicherry, including Sundays and public holidays, between 7 AM and 10 PM without any additional charges.

Doctors prescribe this test to diagnose granulomatosis with polyangiitis in patients with upper airway disease, pulmonary involvement, and glomerulonephritis, investigate rapidly progressive kidney failure of suspected autoimmune origin, and monitor disease activity and relapse risk in confirmed ANCA-associated vasculitis patients on immunosuppressive therapy.

The normal reference range for PR3-ANCA is below 2 U/mL, indicating no significant anti-proteinase 3 antibody activity. Values above this threshold require clinical correlation with symptoms, renal function, urine microscopy, and imaging before a diagnosis of ANCA-associated vasculitis is established.

A positive PR3-ANCA in a patient with compatible clinical features strongly suggests granulomatosis with polyangiitis requiring urgent specialist rheumatology or nephrology evaluation and prompt immunosuppressive treatment. Your doctor will correlate this with MPO-ANCA, renal function, urine microscopy, chest imaging, and tissue biopsy to confirm the diagnosis and determine the most appropriate treatment regimen.

Content Reviewed By

Reviewer
Reviewed by:

Dr. Kovid Pandey

MBBS, General Physician

Last Reviewed: 10th Mar 2026

References

1
Yates M et al.: EULAR/ERA-EDTA Recommendations for the Management of ANCA-Associated Vasculitis, Annals of the Rheumatic Diseases, 2016 — doi.org
2
Jennette JC et al.: 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides, Arthritis and Rheumatism, 2013 — doi.org
3
Lionaki S et al.: Classification of Antineutrophil Cytoplasmic Autoantibody Vasculitides, Arthritis and Rheumatism, 2012 — doi.org
4
Stone JH et al.: Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis, New England Journal of Medicine, 2010 — doi.org
5
Watts RA and Scott DGI: ANCA Vasculitis: To Lump or Split, Rheumatology, 2019 — doi.org

Download Our App & Get Consultation from anywhere.

App Download